Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. Its commercialized products include Ryanodex, a dantrolene sodium for injectable suspension; and Bendeka, a bendamustine hydrochloride injection used for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.